Completed
Phase I Study of Linerixibat in Adults With Moderate Hepatic Impairment and Healthy Controls
NCT05393076
- Conditions
- Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +13 more
- Locations
-
- GSK Investigational Site Orlando, Florida, United States
- GSK Investigational Site San Antonio, Texas, United States